Clinical relevance of biologic factors in male breast cancer

By Meijer-van Gelder M.E.   Look M.P.   Bolt-de Vries J.   Peters H.A.   Klijn J.G.M.   Foekens J.A.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 249-260

Springer Publishing Company

Access to resources Recommend Favorite

Male breast cancer: a review of clinical management

By Agrawal A.   Ayantunde A.   Rampaul R.   Robertson J.  

Breast Cancer Research and Treatment, Vol. 103, Iss. 1, 2007-05 ,pp. : 11-21

Springer Publishing Company

Access to resources Recommend Favorite

Male Breast Cancer: A Population-Based Comparison with Female Breast Cancer in Hong Kong, Southern China: 1997–2006

By Kwong Ava   Chau Wai   Mang Oscar   Wong Connie   Suen Dacita   Leung R.   Wong Kerry   Lee Andrea   Shea Catherine   Morse Elliot   Law Stephen  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1246-1253

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer

By Airoldi M.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 3, 2001-12 ,pp. : 185-195

Springer Publishing Company

Access to resources Recommend Favorite

PALB2 mutations in male breast cancer: a population-based study in Central Italy

By Silvestri Valentina  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 299-301

Springer Publishing Company

Access to resources Recommend Favorite